Focinvez

Active Ingredient(s): Fosaprepitant
FDA Approved: * August 22, 2023
Pharm Company: * Spes Pharmaceuticals Inc.
Category: Nausea & Vomiting

Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting.[1] It may be used together with ondansetron and dexamethasone.[1] It is taken by mouth.[1] Common side effects include tiredness, loss of appetite, diarrhea, abdominal pain, hiccups, itchiness, pneumonia, and blood pressure changes.[1] Other sev... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Focinvez 150 mg/50ml Intravenous Injection
NDC: 70121-2631
Labeler:
Amneal Pharmaceuticals LLC
Focinvez 150 mg/50ml Intravenous Injection
NDC: 82243-1001
Labeler:
Spes Pharmaceuticals Inc.
Focinvez 150 mg/50ml Intravenous Injection
NDC: 82449-231
Labeler:
Steriscience Specialties Private Limited

Related Brands

Drugs with the same active ingredients